Drug Type Monoclonal antibody |
Synonyms anti-PTPRD antibody, 抗PTPRD单抗 |
Target |
Mechanism PTPRD inhibitors(protein tyrosine phosphatase receptor type D inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | US | 30 Oct 2023 |